The 1st China Pharmaceutical Innovation Conference (CPIC), hosted by TONACEA, will be grandly held from July 22 to 24, 2026, at the National Exhibition and Convention Center (Shanghai).

Benchmarking the J.P. Morgan Healthcare Conference, CPIC aims to establish a new paradigm of "Chinese Innovation – Global Translation – Shanghai Transaction." As the "premier window" for global capital and enterprises to gain insight into China's innovation ecosystem, and as the "core hub" for Chinese pharmaceutical companies to upgrade, go global, and connect with the world, CPIC is set to become the definitive barometer for annual investment and collaboration in the global health industry. The conference will feature dozens of dedicated sessions covering numerous hot topics and future directions in health industry innovation investment and global development.

The CPIC Organizing Committee announces that DRAGONHEART has officially become the Cultural Strategic Partner of the 1st China Pharmaceutical Innovation Conference. Liu Dali, Founder of DRAGONHEART and Chairman of the Hong Kong Professional Listing and Overseas Go-Listing Service Alliance, has been invited to serve as Co-Chair of the conference organizing committee. Technology as the bone, culture as the soul. With DRAGONHEART's empowerment, this premier pharmaceutical innovation conference goes beyond technology. Through soulful aesthetics, China's innovative drugs gain the profound spiritual strength of traditional Chinese culture, and CPIC establishes a unique paradigm distinct from J.P. Morgan.

Scan the QR code to register now!
Limited-time early bird tickets at 40% off – grab yours now!!
The overseas registration link will be available soon. Stay tuned!

About DRAGONHEART

DRAGONHEART was founded in 2021 by professionals from multiple disciplines. The core team, having long studied traditional Chinese culture, recognized the consumer demand for culture and its spiritual value behind the rise of "Guochao" (China-chic). To connect Guochao with the roots of Chinese culture, tap into the spiritual power inherent in authentic Chinese cultural heritage, and ultimately establish a new benchmark for Eastern soulful aesthetics on the world stage, they founded DRAGONHEART.

Rooted in traditional Chinese culture as the "trendsetting totem of soulful aesthetics," DRAGONHEART's team extracts the genes of beauty from ancient Chinese national treasures and classics such as the Book of Documents (Shangshu), Tao Te Ching (Daodejing), Book of Changes (Yijing), and Classic of Poetry (Shijing). They awaken the timeless spiritual energy within these works, harmonizing it with the fervent aspirations of the present era, allowing it to blossom in forms that are perceptible and accessible to life.

— As the Book of Changes says, "The Creative (Qian) brings benefit to all under heaven through its beauty." The timeless spiritual energy behind Chinese culture manifests itself through DRAGONHEART's continuous creation of soulful aesthetics visual expressions. It presents perceptible and accessible beauty in various forms, including aesthetic spaces, art installations, cultural and artistic events, trendy apparel, artistic leather accessories, and intellectual properties.

About TONACEA

TONACEA is a premier ecosystem platform in China's biomedical innovation sector. With over 20 years of deep engagement in China's innovative drug development, it has grown into a key organizational force driving China's pharmaceutical innovation and serves as a core hub connecting multinational pharmaceutical companies with local innovation.

TONACEA brings together multinational pharmaceutical companies, biotech firms, investment institutions, research institutes, and regulatory experts, establishing a high-end professional network and knowledge-sharing system that covers the entire R&D value chain. Its business encompasses industry summits, technical forums, customized corporate training, media communications, and strategic consulting. With multiple branches across China, TONACEA has built an operational network that extends nationwide. Its official WeChat account and video channel consistently deliver in-depth industry insights, with perspectives frequently cited by investors and media, earning recognition as a trusted authoritative source within the industry.